Skip to content

CUSPIDATI

Active
Private limited companyfounded 2012active for 14 yearsBilzersteenweg 415, 3700 Tongeren-Borgloon, BelgiumKBO/BCE: BE 0844.612.751
Summary

CUSPIDATI has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €464,645 and a net result of €58,904. Equity is growing by about 8.6% per year across the filed financial years. Its solvency ranks better than 73% of 20,612 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Dental practice
NACE 86230
1 site
Size
€566,252total assets 2025
Staff
1 FTE
Equity
€464,645
Profit
€58,904
Turnover not published (abbreviated or micro format)
Financial health
95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 36 days early2 deeds in the Belgian Official Gazette
Why 95lowers riskLiquidity: current ratio 5.17, cash €410,353Sector: Human health activities (NACE 86)Size: total assets €566,252Equity €464,645 (82.1% of total assets)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 59% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 100=
equity 82.1% of total assets
Liquidity 95-3
short-term debt 17.6% · cash 72.5%
Profitability 82=
return on assets 10.4%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025highest value 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €40,000 on 30-day terms is acceptable
Liquidity ample (current ratio 5.17, compared with 6.48 in 2024, above the usual 1.5; short-term debt: 17.6% and cash: 72.5% of total assets), and 17.9% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 83% on liquidity, 29% on profitability and 43% on growth.

The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Liquidity: current ratio 5.17, cash €410,353
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €566,252
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Equity €464,645 (82.1% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-06-2026, 36 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
36 days early
2024
34 days early
2023
26 days early
2022
35 days early
2021
31 days early
2020
215 days late
2019
164 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 31 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
27-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Annual accounts filedfinancial year 2023 · micro…

Financials · financial year 2025, micro format

Equity
€464,645▲ 3.2%
2024 · €450,066
Total assets
€566,252▲ 8.3%
2024 · €523,053
Net result
€58,904▲ 7.6%
2024 · €54,733
Working capital
€415,021▲ 6.6%
2024 · €389,342
Trend over the years

2021 to 2025, 5 financial years 2018 to 2025, 8 financial years

The operating result recovers in 2025; 2025 is 10% above 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€88,152 2025 Net result€58,904 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Operating result€59,363-€41,704▼ 29.7%€66,035▲ 58.3%€77,624▲ 17.6%€130,549▲ 68.2%€80,351▼ 38.5%€79,804▼ 0.7%€88,152▲ 10.5%
Net result€36,056-€29,155▼ 19.1%€44,324within the sector's middle half▲ 52.0%€53,982within the sector's middle half▲ 21.8%€87,548within the sector's middle half▲ 62.2%€53,798within the sector's middle half▼ 38.6%€54,733within the sector's middle half▲ 1.7%€58,904within the sector's middle half▲ 7.6%
Equity€252,019-€278,174▲ 10.4%€322,498within the sector's middle half▲ 15.9%€342,591within the sector's middle half▲ 6.2%€403,746above the sector's middle half▲ 17.9%€421,488above the sector's middle half▲ 4.4%€450,066above the sector's middle half▲ 6.8%€464,645above the sector's middle half▲ 3.2%
Total assets€297,175-€331,652▲ 11.6%€377,656within the sector's middle half▲ 13.9%€468,954within the sector's middle half▲ 24.2%€471,124within the sector's middle half▲ 0.5%€513,457within the sector's middle half▲ 9.0%€523,053within the sector's middle half▲ 1.9%€566,252within the sector's middle half▲ 8.3%
Debt€45,156-€53,479▲ 18.4%€55,158▲ 3.1%€126,362▲ 129%€67,378▼ 46.7%€91,969▲ 36.5%€72,987▼ 20.6%€101,607▲ 39.2%
Working capital€246,592-€273,640▲ 11.0%€317,915above the sector's middle half▲ 16.2%€306,887above the sector's middle half▼ 3.5%€366,277above the sector's middle half▲ 19.4%€373,118above the sector's middle half▲ 1.9%€389,342above the sector's middle half▲ 4.3%€415,021above the sector's middle half▲ 6.6%
Solvency84.8%-83.9%▼ 0.9pp85.4%above the sector's middle half▲ 1.5pp73.1%within the sector's middle half▼ 12.3pp85.7%above the sector's middle half▲ 12.6pp82.1%within the sector's middle half▼ 3.6pp86.0%above the sector's middle half▲ 4.0pp82.1%within the sector's middle half▼ 4.0pp
Current ratio6.46-6.12▼ 0.346.76above the sector's middle half▲ 0.653.47within the sector's middle half▼ 3.306.60above the sector's middle half▲ 3.135.15within the sector's middle half▼ 1.466.48within the sector's middle half▲ 1.345.17within the sector's middle half▼ 1.32
Return on assets (ROA)12.1%-8.8%▼ 3.3pp11.7%within the sector's middle half▲ 2.9pp11.5%within the sector's middle half▼ 0.2pp18.6%within the sector's middle half▲ 7.1pp10.5%within the sector's middle half▼ 8.1pp10.5%within the sector's middle half=10.4%within the sector's middle half▼ 0.1pp
Staff (FTE)1-1=1within the sector's middle half=1=1=1=1=1=
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated or micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €566,252
Fixed assets €51,624 ▼ 17.7%
Current assets €514,629 ▲ 11.8%
Equity and liabilities €566,252
Equity €464,645 ▲ 3.2%
Debt €101,607 ▲ 39.2%
Debt's share of the balance-sheet total rises from 14.0% to 17.9%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€99,252▲
2024 · €88,659
Cash flow
€70,004▲
2024 · €63,587
Debt to equity
0.22▲
2024 · 0.16
ROE
12.7%▲
2024 · 12.2%
Interest coverage
over 100
2024 · over 100
Debt ≤ 1 year
€99,607▲
2024 · €70,987
Income taxes
€29,034▲
2024 · €26,435
Staff costs
€65,031▲
2024 · €64,262
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 34,695 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 95.3% are still going.

  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
3.9% stopped otherwise
95.3% still going

For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,475 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 34,695 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 46 lines
Balance sheet Code20242025
Assets
Total assets20/58€523,053€566,252▲
Fixed assets21/28€62,724€51,624▼
Tangible fixed assets22/27€62,724€51,624▼
Plant, machinery and equipment23€56,266€47,023▼
Furniture and vehicles24€6,458€4,601▼
Current assets29/58€460,329€514,629▲
Amounts receivable within one year40/41€2,206€849▼
Trade receivables40€2,206€0▼
Other amounts receivable41€0€849▲
Current investments50/53€100,000€100,000=
Cash at bank and in hand54/58€356,151€410,353▲
Deferred charges and accrued income490/1€1,972€3,427▲
Equity and liabilities
Total equity and liabilities10/49€523,053€566,252▲
Equity10/15€450,066€464,645▲
Contributions10/11€18,600€18,600=
Reserves13€431,466€446,045▲
Distributable reserves133€431,466€446,045▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€72,987€101,607▲
Amounts payable within one year42/48€70,987€99,607▲
Trade debts44€1,815€1,557▼
Suppliers440/4€1,815€1,557▼
Taxes, remuneration and social security45€9,226€17,175▲
Taxes450/3€1,795€4,906▲
Remuneration and social security454/9€7,431€12,269▲
Other amounts payable47/48€59,946€80,875▲
Accrued charges and deferred income492/3€2,000€2,000=
Income statement Code20242025
Remuneration, social security and pensions62€64,262€65,031▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€8,855€11,100▲
Other operating charges640/8€693€679▼
Gross operating margin9900€153,614€164,962▲
Operating profit (loss)9901€79,804€88,152▲
Financial income75/76B€2,136€568▼
Recurring financial income75€2,136€568▼
Financial charges65/66B€772€782▲
Recurring financial charges65€772€782▲
Profit (loss) for the period before taxes9903€81,168€87,938▲
Income taxes67/77€26,435€29,034▲
Profit (loss) for the period9904€54,733€58,904▲
Profit (loss) for the period to be appropriated9905€54,733€58,904▲
Appropriation of the result
Profit (loss) to be appropriated9906€54,733€58,904▲
Transfer from equity791/2€26,155€44,324▲
Transfer to equity691/2€54,733€58,904▲
To other reserves6921€54,733€58,904▲
Profit to be distributed694/7€26,155€44,324▲
Return on contributions (dividend)694€26,155€44,324▲

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20182019202020212022202320242025Change
Remuneration, social security and pensions62---€31,300€41,386€57,276€64,262€65,031▲ 1.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2,826€893€908€1,100€4,647€6,428€8,855€11,100▲ 25.4%
Other operating charges640/8---€1,027€654€1,049€693€679▼ 2.0%
Gross operating margin9900€89,694€72,371€94,185€111,052€177,237€145,105€153,614€164,962▲ 7.4%
Operating profit (loss)9901€59,363€41,704€66,035€77,624€130,549€80,351€79,804€88,152▲ 10.5%
Financial income75/76B----€10€336€2,136€568▼ 73.4%
Recurring financial income75€0-€66-€10€336€2,136€568▼ 73.4%
Financial charges65/66B---€741€1,240€858€772€782▲ 1.2%
Recurring financial charges65€1,932€2,084€1,505€741€1,240€858€772€782▲ 1.2%
Profit (loss) for the period before taxes9903€57,431€39,620€64,595€76,883€129,319€79,830€81,168€87,938▲ 8.3%
Income taxes67/77€21,375€10,466€20,270€22,901€41,772€26,032€26,435€29,034▲ 9.8%
Profit (loss) for the period9904€36,056€29,155€44,324€53,982€87,548€53,798€54,733€58,904▲ 7.6%
Profit (loss) for the period to be appropriated9905€36,056€29,155€44,324€53,982€87,548€53,798€54,733€58,904▲ 7.6%
Line20182019202020212022202320242025Change
Assets
Total assets20/58€297,175€331,652€377,656€468,954€471,124€513,457€523,053€566,252▲ 8.3%
Fixed assets21/28€5,427€4,534€4,583€37,704€39,470€50,370€62,724€51,624▼ 17.7%
Tangible fixed assets22/27€5,427€4,534€4,583€37,704€39,470€50,370€62,724€51,624▼ 17.7%
Land and buildings22---€760€0----
Plant, machinery and equipment23---€34,868€37,439€43,851€56,266€47,023▼ 16.4%
Furniture and vehicles24---€2,076€2,030€6,519€6,458€4,601▼ 28.8%
Current assets29/58€291,749€327,118€373,072€431,250€431,655€463,087€460,329€514,629▲ 11.8%
Amounts receivable within one year40/41€60€5,124€5,118€870€0€1,285€2,206€849▼ 61.5%
Trade receivables40---€870€0-€2,206€0▼ 100%
Other amounts receivable41-----€1,285€0€849-
Current investments50/53-----€150,000€100,000€100,000=
Cash at bank and in hand54/58€291,689€321,994€367,954€429,397€430,570€310,647€356,151€410,353▲ 15.2%
Deferred charges and accrued income490/1---€984€1,085€1,155€1,972€3,427▲ 73.8%
Equity and liabilities
Total equity and liabilities10/49€297,175€331,652€377,656€468,954€471,124€513,457€523,053€566,252▲ 8.3%
Equity10/15€252,019€278,174€322,498€342,591€403,746€421,488€450,066€464,645▲ 3.2%
Contributions10/11€18,600€18,600-€18,600€18,600€18,600€18,600€18,600=
Reserves13€233,419€259,574€303,898€323,991€385,146€402,888€431,466€446,045▲ 3.4%
Non-distributable reserves130/1---€1,860€0----
Reserves not available under the articles1311---€1,860€0----
Distributable reserves133---€322,131€385,146€402,888€431,466€446,045▲ 3.4%
Profit (loss) carried forward14----€0€0€0€0-
Amounts payable17/49€45,156€53,479€55,158€126,362€67,378€91,969€72,987€101,607▲ 39.2%
Amounts payable within one year42/48€45,156€53,479€55,158€124,362€65,378€89,969€70,987€99,607▲ 40.3%
Trade debts44€189€2,771€4,532€29,137€142€5,878€1,815€1,557▼ 14.2%
Suppliers440/4---€29,137€142€5,878€1,815€1,557▼ 14.2%
Taxes, remuneration and social security45---€23,581€29,837€15,159€9,226€17,175▲ 86.2%
Taxes450/3---€15,200€19,860€2,921€1,795€4,906▲ 173%
Remuneration and social security454/9---€8,381€9,977€12,238€7,431€12,269▲ 65.1%
Other amounts payable47/48---€71,645€35,399€68,932€59,946€80,875▲ 34.9%
Accrued charges and deferred income492/3---€2,000€2,000€2,000€2,000€2,000=
Line20182019202020212022202320242025Change
Profit (loss) for the period9904€36,056€29,155€44,324€53,982€87,548€53,798€54,733€58,904▲ 7.6%
+ Depreciation and write-downs630€2,826€893€908€1,100€4,647€6,428€8,855€11,100▲ 25.4%
Operating cash flow (approximation)€38,881€30,047€45,232€55,082€92,195€60,226€63,587€70,004▲ 10.1%
Investment in fixed assets (approximation)-€0-€957-€34,220-€6,413-€17,328-€21,209€0-
Change in cash-€30,306€45,960€61,442€1,173-€119,923€45,504€54,202▲ 19.1%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 14 filings with the National Bank
Financial year Type Filed Reference
31-12-2025 micro format 25-06-2026 2026-00196158
31-12-2024 micro format 27-06-2025 2025-00184972
31-12-2023 micro format 05-07-2024 2024-00223066
31-12-2022 micro format 26-06-2023 2023-00184959
31-12-2021 micro format 30-06-2022 2022-20129128
31-12-2020 micro format 03-03-2022 2022-07000036
31-12-2019 micro format 11-01-2021 2021-00600053
31-12-2018 abbreviated format 31-08-2019 2019-63400076
31-12-2017 abbreviated format 31-08-2018 2018-61600040
31-12-2016 abbreviated format 31-08-2017 2017-58500340

Show all 14 filings

Similar companies · same sector, comparable size

Of the 6,939 active companies whose main activity is dental practice (NACE 86230), figures are known for 4,365. 3,567 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 2 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

On 22 March 2012, CUSPIDATI was incorporated.1 Total assets went from €297,175 in 2018 to €566,252 in 2025 and headcount from 1 to 1 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
25-06
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
27-06
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
05-07
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
26-06
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial Highest result from 2018 to 2025net €87,548 ▲62.2%
Operating result €130,549, net result €87,548, both a record.
30-06
NBB filing Annual accounts filed
financial year 2021 · micro format
03-03
NBB filing Annual accounts filed
financial year 2020 · micro format · 215 days late
2021
11-01
NBB filing Annual accounts filed
financial year 2019 · micro format · 164 days late
2019
31-08
NBB filing Annual accounts filed
financial year 2018 · abbreviated format · 31 days late
2018
31-08
NBB filing Annual accounts filed
financial year 2017 · abbreviated format · 31 days late
2017
31-08
NBB filing Annual accounts filed
financial year 2016 · abbreviated format · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 14 annual accounts filed, the latest 10 are here; all 14 are under Financials.
0 of 2 deeds read
About the unread acts

We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded22-03-2012
Financial year end31-12
Activities, NACEBEL 2025
86230Dental practice
82990Other business support services
E-invoicing
Reachable via Peppol
Peppol ID 0208:0844612751
Also 9925:BE0844612751
Registered 05-03-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 27 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Tongeren-Borgloon · 1 establishment unit since 2012
registered office establishment The establishment unit on the map
Ground area
1,409 m²
Building footprint
268 m²
Building volume
1,694 m³
Parcel 73069B0586/00E000, Flanders · tallest building 9.5 m. Linked by address, not a title deed.
1 establishment unit
Cuspidati
Bilzersteenweg 415, 3700 Tongeren-BorgloonDental practice
since 2012unit no. 2.240.512.928
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
73069B0586/00E000 Flanders 1,409 m² 1 · 268 m² 9.5 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.